VOGT-KOYANAGI-HARADA DISEASE

VOGT-KOYANAGI-HARADA DISEASE was reported 220 times

VOGT-KOYANAGI-HARADA DISEASE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Photoactivated Radical Generator [EPC] 4 0.0312
1 Programmed Death Receptor-1 Blocking Antibody [EPC] 84 0.0009
2 CTLA-4-directed Blocking Antibody [EPC] 35 0.0007
3 Rifamycin Antibacterial [EPC] 11 0.0003
4 Non-Standardized Plant Allergenic Extract [EPC] 4 0.0002
5 Carbonic Anhydrase Inhibitor [EPC] 3 0.0001
6 Thymic Stromal Lymphopoietin Blocker [EPC] 1 0.0001
7 Vitamin K [EPC] 1 0.0001
8 Glinide [EPC] 1 0.0001
9 CD52-directed Cytolytic Antibody [EPC] 2 0.0001
10 Antifibrinolytic Agent [EPC] 1 0.0001
11 Quinolone Antimicrobial [EPC] 1 0.0001
12 CD30-directed Immunoconjugate [EPC] 1 0.0001
13 Lipid-based Polyene Antifungal [EPC] 1 0.0001
14 Prostacyclin Receptor Agonist [EPC] 2 0.0001
15 HER2/neu Receptor Antagonist [EPC] 5 0.0001
16 Prostaglandin Analog [EPC] 6 0.0001
17 Interleukin-1 Receptor Antagonist [EPC] 1 0.0001
18 Soluble Guanylate Cyclase Stimulator [EPC] 2 0.0001
19 Platinum-based Drug [EPC] 16 0.0001
20 Orexin Receptor Antagonist [EPC] 1 0.0001
21 Calcineurin Inhibitor Immunosuppressant [EPC] 7 0.0001
22 Non-Standardized Food Allergenic Extract [EPC] 4 0.0001
23 Microtubule Inhibitor [EPC] 8 0.0000
24 Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] 1 0.0000
25 Antimetabolite Immunosuppressant [EPC] 1 0.0000
26 Programmed Death Ligand-1 Blocker [EPC] 1 0.0000
27 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
28 Interleukin-6 Receptor Antagonist [EPC] 6 0.0000
29 Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] 2 0.0000
30 Folate Analog Metabolic Inhibitor [EPC] 16 0.0000
31 Nucleoside Analog Antiviral [EPC] 3 0.0000
32 Leukotriene Receptor Antagonist [EPC] 1 0.0000
33 Corticosteroid [EPC] 42 0.0000
34 Tumor Necrosis Factor Blocker [EPC] 32 0.0000
35 Purine Antimetabolite [EPC] 3 0.0000
36 Interleukin-17A Antagonist [EPC] 1 0.0000
37 Janus Kinase Inhibitor [EPC] 4 0.0000
38 Polyene Antifungal [EPC] 1 0.0000
39 Kinase Inhibitor [EPC] 13 0.0000
40 Nucleoside Metabolic Inhibitor [EPC] 6 0.0000
41 Epidermal Growth Factor Receptor Antagonist [EPC] 1 0.0000
42 Hepatitis C Virus NS5A Inhibitor [EPC] 1 0.0000
43 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 2 0.0000
44 Complement Inhibitor [EPC] 1 0.0000
45 Vascular Endothelial Growth Factor Inhibitor [EPC] 3 0.0000
46 Histamine-2 Receptor Antagonist [EPC] 2 0.0000
47 alpha-Adrenergic Blocker [EPC] 2 0.0000
48 Androgen Receptor Inhibitor [EPC] 1 0.0000
49 Vitamin D [EPC] 4 0.0000
50 Topoisomerase Inhibitor [EPC] 1 0.0000
51 Aldosterone Antagonist [EPC] 2 0.0000
52 CD20-directed Cytolytic Antibody [EPC] 4 0.0000
53 Vitamin B12 [EPC] 4 0.0000
54 Xanthine Oxidase Inhibitor [EPC] 2 0.0000
55 Integrin Receptor Antagonist [EPC] 1 0.0000
56 Nonsteroidal Anti-inflammatory Drug [EPC] 15 0.0000
57 Endothelin Receptor Antagonist [EPC] 2 0.0000
58 Interleukin-12 Antagonist [EPC] 1 0.0000
59 Vitamin C [EPC] 4 0.0000
60 Interleukin-23 Antagonist [EPC] 1 0.0000
61 Alkylating Drug [EPC] 2 0.0000
62 Interleukin-4 Receptor alpha Antagonist [EPC] 4 0.0000
63 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
64 Selective T Cell Costimulation Modulator [EPC] 1 0.0000
65 Calcium [EPC] 1 0.0000
66 beta-Adrenergic Blocker [EPC] 2 0.0000
67 Azole Antifungal [EPC] 1 0.0000
68 Phosphodiesterase 4 Inhibitor [EPC] 1 0.0000
69 HMG-CoA Reductase Inhibitor [EPC] 2 0.0000
70 Interferon beta [EPC] 1 0.0000
71 RANK Ligand Inhibitor [EPC] 1 0.0000
72 GLP-1 Receptor Agonist [EPC] 2 0.0000
73 Loop Diuretic [EPC] 2 0.0000
74 Proton Pump Inhibitor [EPC] 2 0.0000
75 Platelet Aggregation Inhibitor [EPC] 1 0.0000
76 Benzodiazepine [EPC] 1 0.0000